Automated radiosynthesis of [18F]ML-10, a PET radiotracer dedicated to apoptosis imaging, on a TRACERLab FX-FN module

Molecular Imaging and Biology

Volumn 15, Issue 1, 2013, Pages 12-18

  Sobrio, Franck ^a,b,c   Médoc, Marie ^a,b,c   Martial, Ludovic ^a,b,c   Delamare, Jérôme ^a,b,c   Barré, Louisa ^a,b,c  

^a UMR 6301 ISTCT ^*  (France)

^b CNRS   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

Apoptosis; Fluorine 18; ML 10; PET; Positron emission tomography; Radiopharmaceuticals; Radiosynthesis

Indexed keywords

2 (5 FLUOROPENTYL) 2 METHYL MALONIC ACID F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; APOPTOSIS; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORINE NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY CONTROL; RADIOACTIVITY; RADIOSYNTHESIS;

APOPTOSIS; KINETICS; METHYLMALONIC ACID; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84873099664     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-012-0574-y     Document Type: Article

References (19)

1. Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9:231-241
2. Faust A, Hermann S, Wagner S et al (2009) Molecular imaging of apoptosis in vivo with scintigraphic and optical biomarkers - a status report. Anticancer Agents Med Chem 9:968-985
3. Blankenberg FG (2008) In vivo imaging of apoptosis. Cancer Biol Ther 7:1525-1532
4. Blankenberg FG (2008) In vivo detection of apoptosis [proceeding]. J Nucl Med 49(Suppl 2):81S-95S
5. De Saint-Hubert M, Prinsen K, Mortelmans L, Verbruggen A, Mottaghy FM (2009) Molecular imaging of cell death. Methods 48:178-187
6. Lahorte CM, Vanderheyden JL, Steinmetz N et al (2004) Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging 31:887-919
7. Nguyen QD, Aboagye EO (2010) Imaging the life and death of tumors in living subjects: preclinical PET imaging of proliferation and apoptosis. Integr Biol (Cambridge) 2:483-495
8. Michalski MH, Chen X (2011) Molecular imaging in cancer treatment. Eur J Nucl Med Mol Imaging 38:358-377
9. Haberkorn U, Markert A, Mier W, Askoxylakis V, Altmann A (2011) Molecular imaging of tumor metabolism and apoptosis. Oncogene 30:4141-4151
10. Aboagye EO (2010) The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture [proceeding]. Br J Radiol 83:814-822
11. Reshef A, Shirvan A, Akselrod-Ballin A, Wall A, Ziv I (2010) Small-molecule biomarkers for clinical PET imaging of apoptosis. J Nucl Med 51:837-840
12. Cohen A, Shirvan A, Levin G et al (2009) From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res 19:625-637
13. Reshef A, Shirvan A, Waterhouse RN et al (2008) Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J Nucl Med 49:1520-1528
14. 18F-ML-10, a PET tracer for apoptosis: first human study. J Nucl Med 52:720-725
15. Larson S (2010) Newsline, oncology. J Nucl Med 51:19N-25N
16. 18F]FDG preparations. Nucl Med Biol 24:193-195
17. Klok RP, Windhorst AD (2006) Residual solvent analysis by gas chromatography in radiopharmaceutical formulations containing up to 12 % ethanol. Nucl Med Biol 33:935-938
18. Mahidhar YV, Rajesh M, Chaudhuri A (2004) Spacer-arm modulated gene delivery efficacy of novel cationic glycolipids: design, synthesis, and in vitro transfection biology. J Med Chem 47:3938-3948
19. Ziv I, Shirvan A (2005) NST Neurosurvival technologies Ltd. Perturbed membrane-binding compounds and methods of using the same [patent]. WO/2005/067388